title: Points for Consideration for dengue vaccine introduction - recommendations by the Dengue Vaccine Initiative.
abstract: Dengue is a public health problem in the tropics and subtropics. There are several vaccine candidates in clinical development. However, there may be gaps in the new vaccine introduction after vaccine licensure before it becomes available in developing countries. In anticipation of the first dengue vaccine candidate to be licensed, Dengue Vaccine Initiative (DVI) and, its predecessor, Pediatric Dengue Vaccine Initiative (PDVI) have been working on points for consideration to accelerate evidence-based dengue vaccine introduction, once a vaccine becomes available. In this paper, we review the history of PDVI and its successor, the DVI, and elaborate on the points of consideration for dengue vaccine introduction.
authors.affiliation: a International Vaccine Institute - Dengue Vaccine Initiative , Seoul , The Republic of Korea.
authors.forename: Jacqueline Kyungah
authors.initials: JK
authors.lastname: Lim
authors.affiliation: a International Vaccine Institute - Dengue Vaccine Initiative , Seoul , The Republic of Korea.
authors.forename: Yong-Seok
authors.initials: YS
authors.lastname: Lee
authors.affiliation: b Global Health and Vaccinology Programme, Lee Kong Chian School of Medicine , Novena Campus , Singapore.
authors.forename: Annelies
authors.initials: A
authors.lastname: Wilder-Smith
authors.affiliation: c Senergues Consult, Vaccines , Toulouse , France.
authors.forename: Georges
authors.initials: G
authors.lastname: Thiry
authors.affiliation: d RTM Associates , Sedona , AZ , USA.
authors.forename: Richard
authors.initials: R
authors.lastname: Mahoney
authors.affiliation: a International Vaccine Institute - Dengue Vaccine Initiative , Seoul , The Republic of Korea.
authors.forename: In-Kyu
authors.initials: IK
authors.lastname: Yoon
mesh_terms: D003657:Decision Making; D003715:Dengue / Q000453:epidemiology / Q000517:prevention & control*; D053059:Dengue Vaccines / Q000008:administration & dosage / Q000276:immunology* / Q000302:isolation & purification; D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D006291:Health Policy; D006801:Humans; D017589:Immunization Programs; D014611:Vaccination / Q000706:statistics & numerical data
chemical_list: D053059:Dengue Vaccines
keywords: Dengue; Dengue Vaccine Initiative; introduction; points for consideration; vaccine